Article info

Original article
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

Authors

  1. Correspondence to Dr David J Serisier, Department of Respiratory Medicine, Level 9 Mater Adult Hospital, Raymond Tce, South Brisbane, QLD 4101, Australia; david.serisier{at}mater.org.au
View Full Text

Citation

Serisier DJ, Bilton D, De Soyza A, et al
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

Publication history

  • Received January 2, 2013
  • Revised April 6, 2013
  • Accepted April 18, 2013
  • First published May 16, 2013.
Online issue publication 
August 09, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.